Nora C.
- Country
- Italy
- Department
- Gastroenterology Unit
Research Overview
- An Open Label, Phase 2 Study to Evaluate the Effect of A3907 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Adults with Primary Sclerosing Cholangitis (PSC)
- Efficacy and Safety Evaluation of Elafibranor in Adult Patients with Primary Biliary Cholangitis: A Phase III Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Elafibranor Safety and Efficacy in Adult Patients with Primary Sclerosing Cholangitis: A Phase II Multicenter, Double-Blind, Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 26 of 124 partner sites.
Specializations
Primary Biliary Cholangitis Research
This investigator specializes in treating primary biliary cholangitis (PBC), with particular focus on managing associated symptoms like cholestatic pruritus and cognitive dysfunction. Their research extends to evaluating novel therapeutic approaches for PBC patients with both cirrhotic and non-cirrhotic conditions.
- Treatment of PBC-related itching
- Management of PBC-related fatigue
- Cirrhosis complications in PBC
The investigator works with innovative treatments including volixibat, golexanolone, and elafibranor for PBC management.
Primary Sclerosing Cholangitis Focus
The investigator demonstrates expertise in primary sclerosing cholangitis (PSC) research, particularly investigating therapeutic interventions for symptom management and disease progression. Their work includes evaluation of treatments for PSC-related pruritus and assessment of novel compounds.
- PSC treatment development
- Management of biliary strictures
- Pruritus control in PSC
Their research encompasses both short-term symptom management and long-term disease modification approaches.
Cholestatic Conditions
The investigator's expertise extends to broader cholestatic disorders and their complications. Their research focuses on developing therapeutic solutions for cholestasis-related symptoms and improving patient quality of life.
- Cholestatic disease management
- Novel therapeutic approaches
- Long-term safety evaluations
The research includes evaluation of various therapeutic agents for managing cholestatic conditions and their symptoms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.